Evaluation of the Vitek System to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime
- 1 October 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 32 (2) , 107-110
- https://doi.org/10.1016/s0732-8893(98)00051-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antimicrobial Susceptibility Testing: General Principles and Contemporary PracticesClinical Infectious Diseases, 1998
- Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United StatesDiagnostic Microbiology and Infectious Disease, 1998
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- Microbiologic and pharmacodynamic principals applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: Analysis of the correlations between in vitro test results and clinical responseDiagnostic Microbiology and Infectious Disease, 1997
- Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methodsDiagnostic Microbiology and Infectious Disease, 1997
- Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patientThe American Journal of Medicine, 1996
- Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patientsThe American Journal of Medicine, 1996
- Susceptibility of bacterial isolates to β-lactam antibiotics from U.S. clinical trials over a 5-year periodThe American Journal of Medicine, 1996
- Serious interpretive error among three commercial systems for susceptibility testing of aztreonamDiagnostic Microbiology and Infectious Disease, 1995
- Interpretive errors using an automated system for the susceptibility testing of imipenem and aztreonamDiagnostic Microbiology and Infectious Disease, 1995